Results 341 to 350 of about 4,769,883 (431)

Determinants of Self‐Management Behavior in Gout: A Scoping Review

Arthritis Care &Research, Volume 77, Issue 4, Page 534-544, April 2025.
Objective This study aimed to identify modifiable determinants of self‐management behavior in patients with gout. Methods Four databases (Medline, Embase, PsycINFO, and CINAHL) were searched using terms related to gout, self‐management, and determinants of behavior as described in the Theoretical Domains Framework (TDF).
Jeffrey van der Ven, Bart J. F. van den Bemt, Marcel Flendrie, Johanna E. Vriezekolk, Lise M. Verhoef   +4 more
wiley   +1 more source

Clinical characteristics of lymphoma patients presenting with fever of unknown origin misdiagnosed with connective tissue diseases. [PDF]

Ann Hematol
Zhang X, Zhang Q, Cao X, Wang Y, Huang X, Jiao Y.   +5 more
europepmc   +1 more source

Pharmacokinetics, Efficacy, and Safety of Upadacitinib in Pediatric Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: An Interim Analysis of an Open‐Label, Phase 1 Trial

Arthritis Care &Research, Volume 77, Issue 5, Page 584-593, May 2025.
Objective This work aimed to evaluate the pharmacokinetics, efficacy, and safety of upadacitinib, an oral selective JAK inhibitor, in pediatric patients with polyarticular‐course juvenile idiopathic arthritis (pcJIA). Methods In an open‐label, phase 1 study (SELECT‐YOUTH), enrolled patients, aged 2 to <18 years with pcJIA, received body weight–based ...
Hermine I. Brunner, Anna Shmagel, Gerd Horneff, Ivan Foeldvari, Jordi Antón, Athimalaipet V. Ramanan, Yuli Qian, Kristina Unnebrink, Shuai Hao, Heidi S. Camp, Nasser Khan, Wei Liu, Mohamed‐Eslam F. Mohamed   +12 more
wiley   +1 more source

Corrigendum: Scleroderma and Scleroderma-like syndromes

Frontiers in Immunology
Katarzyna Romanowska-Próchnicka, Martyna Dziewit, Aleksandra Lesiak, Adam Reich, Marzena Olesińska   +4 more
doaj   +1 more source

Case report: Primary cardiac synovial sarcoma with suspected connective tissue disease diagnosed by EBUS-TBMB. [PDF]

Front Med (Lausanne)
Feng Y, Wu C, Chi J, Li L, Wang P, Guo R.   +5 more
europepmc   +1 more source

Incidence of and Risk of Mortality After Hip Fractures in Rheumatoid Arthritis Relative to the General Population

Arthritis Care &Research, Volume 77, Issue 5, Page 604-613, May 2025.
Objective Osteoporosis, a known complication of rheumatoid arthritis (RA), increases the risk of hip fracture, which is associated with high morbidity and mortality. Fracture risk estimates in patients with RA treated with contemporary treatment strategies are lacking.
C. Allyson Jones, Pierre Guy, Hui Xie, Eric C. Sayre, Kai Zhao, Diane Lacaille   +5 more
wiley   +1 more source

Assessing pulmonary vascular remodeling in connective tissue disease-associated interstitial lung disease: a CT-based quantitative analysis. [PDF]

Quant Imaging Med Surg
Li R, Liu S, Wang X, Wang R, E L.
europepmc   +1 more source

Immunosuppressive Drugs in Early Systemic Sclerosis and Prevention of Damage Accrual

Arthritis Care &Research, Volume 77, Issue 5, Page 640-648, May 2025.
Objective Organ damage in patients with systemic sclerosis (SSc) in individual organs such as the lungs may be prevented by receiving immunosuppressive drugs (ISs). A new measure of global organ damage, the Scleroderma Clinical Trials Consortium Damage Index (SCTC‐DI), has allowed us to investigate whether receiving ISs may reduce global organ damage ...
Murray Baron, Mandana Nikpour, Dylan Hansen, Susanna Proudman, Wendy Stevens, on behalf of the Australian Scleroderma Interest Group and the Canadian Scleroderma Research Group, Joanne Sahhar, Nava Ferdowsi, Kathleen Morrisroe, Laura Ross, Gene Siew Ngian, Jennifer Walker, Janet Roddy, Lauren Host, Mohammed Osman, Peter Docherty, Paul Fortin, Marvin Jacob Fritzler, Genevieve Gyger, Alena Ikic, Niall Jones, Elzbieta Kaminska, Maggie Larche, Sophie Ligier, Ada Man, Ariel Masetto, Janet Pope, David Robinson, Tatiana Sofia Rodriguez‐Reyna, Mianbo Wang   +29 more
wiley   +1 more source

European Reference Network (ERN) ReCONNET methodology for the cross-cultural adaptation of instruments for research and care in the context of rare connective tissue diseases (CROSSADAPT). [PDF]

Orphanet J Rare Dis
Arnaud L, Sander O, Rednic S, Mertz P, Faria R, Crisafulli F, Silva-Ribeiro S, Kawka L, Sztejkowski C, Düsing C, Rose T, Lamas A, Vasconcelos C, Fontana G, Semeraro P, Neagu T, Resteu M, Damian L, Pamfil C, Bucsa C, Matthews LJ, Talarico R, Mosca M, Turchetti G, Thibault T, Devilliers H.   +25 more
europepmc   +1 more source

Eltrombopag for the treatment of refractory connective tissue disease-related thrombocytopenia: a pilot study of 52 cases. [PDF]

Arthritis Res Ther
Deng S, Wang B, Hu Z, Cai S, Dong L.
europepmc   +1 more source